Swiss SMI Rises as Defensives Lead Gains

The move also came against a backdrop of fragile tone on Wall Street, where recent records in the Nasdaq and S&P 500 look vulnerable if earnings fail to justify the scale of artificial-intelligence spending. That matters for Zurich because the Swiss market is heavily weighted toward defensives and quality compounders, making it a relative haven when investors question whether global equities can keep extending gains. The latest technical backdrop for the SMI is mixed: the index remains above its 200-day moving average but below the 50-day moving average, with RSI readings in the mid-40s suggesting neither oversold panic nor a decisive trend reversal.

Within the index, investors leaned into the usual havens. Swisscom led the pack with a 1.6% gain, while Roche rose 1.5%, Novartis 1.4% and Sandoz 1.2%. That strength underlines the market’s preference for earnings visibility over cyclical exposure when macro uncertainty is rising. Nestlé added 0.5%, but that was offset by weakness in financials and industrials: UBS fell 0.9%, Julius Bär dropped 2.3%, ABB lost 0.7% and Holcim slipped 1%. VAT Group was the day’s laggard, down 2.5%.

The pattern is consistent with a market that is not yet committing to a full-risk rally. Oil’s pullback was only modest, with Brent still above $101 a barrel, and transport bottlenecks in the Gulf are keeping supply risks alive. At the same time, Europe’s bond market remains sensitive to French sovereign stress, limiting the scope for a clean rotation into cyclicals. For Swiss investors, that leaves the SMI’s large healthcare and telecom names as the natural beneficiaries of uncertainty, while banks, industrials and more rate-sensitive names stay under pressure.

There was some stock-specific support in the broader market. Amrize edged 0.2% lower after Research Partners cut its target price but kept an “add” recommendation, while Montana Aerospace jumped 3.5% after reaffirming its 2026 flight path and said next year’s update would follow later. But the broader message for investors is that the Swiss market’s near-term direction will likely depend less on domestic news flow than on the next reads from U.S. earnings, bond yields and energy prices.

If global yields stabilise and earnings season confirms that higher AI spending is translating into profits and cash flow, the SMI could extend its recovery. If not, the market’s defensive leadership may prove to be less a sign of strength than a warning that investors are still paying up for shelter.